REGENERON PHARMACEUTICALS INC COM STK USD0.001REGENERON PHARMACEUTICALS INC COM STK USD0.001REGENERON PHARMACEUTICALS INC COM STK USD0.001

REGENERON PHARMACEUTICALS INC COM STK USD0.001

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
10.97USD
Revenue estimate
‪3.41 B‬USD
Market capitalization
‪99.55 B‬USD
‪3.95 B‬USD
‪13.12 B‬USD
‪105.50 M‬
Beta (1Y)
0.54

About Regeneron Pharmaceuticals, Inc.

CEO
Leonard S. Schleifer
Headquarters
Tarrytown
Employees (FY)
‪13.45 K‬
Founded
1988
FIGI
BBG00JRY9CR9
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0R2M is 904.8 USD — it has increased by 0.71% in the past 24 hours. Watch REGENERON PHARMACEUTICALS INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange REGENERON PHARMACEUTICALS INC COM STK USD0.001 stocks are traded under the ticker 0R2M.
REGENERON PHARMACEUTICALS INC COM STK USD0.001 is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
0R2M stock is 0.73% volatile and has beta coefficient of 0.54. Track REGENERON PHARMACEUTICALS INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is REGENERON PHARMACEUTICALS INC COM STK USD0.001 there?
0R2M earnings for the last quarter are 11.86 USD per share, whereas the estimation was 10.73 USD resulting in a 10.52% surprise. The estimated earnings for the next quarter are 10.17 USD per share. See more details about REGENERON PHARMACEUTICALS INC COM STK USD0.001 earnings.
REGENERON PHARMACEUTICALS INC COM STK USD0.001 revenue for the last quarter amounts to ‪3.43 B‬ USD despite the estimated figure of ‪3.29 B‬ USD. In the next quarter revenue is expected to reach ‪3.23 B‬ USD.
Yes, you can track REGENERON PHARMACEUTICALS INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
0R2M stock has risen by 0.10% compared to the previous week, the month change is a 6.63% fall, over the last year REGENERON PHARMACEUTICALS INC COM STK USD0.001 has showed a 12.14% increase.
0R2M net income for the last quarter is ‪1.16 B‬ USD, while the quarter before that showed ‪1.01 B‬ USD of net income which accounts for 15.06% change. Track more REGENERON PHARMACEUTICALS INC COM STK USD0.001 financial stats to get the full picture.
Today REGENERON PHARMACEUTICALS INC COM STK USD0.001 has the market capitalization of ‪99.55 B‬, it has increased by 0.67% over the last week.
No, 0R2M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0R2M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENERON PHARMACEUTICALS INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
0R2M reached its all-time high on Feb 28, 2024 with the price of 998.6 USD, and its all-time low was 274.2 USD and was reached on Oct 3, 2019. View more price dynamics on 0R2M chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪13.45 K‬ employees. See our rating of the largest employees — is REGENERON PHARMACEUTICALS INC COM STK USD0.001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REGENERON PHARMACEUTICALS INC COM STK USD0.001 technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REGENERON PHARMACEUTICALS INC COM STK USD0.001 stock shows the buy signal. See more of REGENERON PHARMACEUTICALS INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on REGENERON PHARMACEUTICALS INC COM STK USD0.001 future price: according to them, 0R2M price has a max estimate of 1189.00 USD and a min estimate of 720.00 USD. Watch 0R2M chart and read a more detailed REGENERON PHARMACEUTICALS INC COM STK USD0.001 stock forecast: see what analysts think of REGENERON PHARMACEUTICALS INC COM STK USD0.001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENERON PHARMACEUTICALS INC COM STK USD0.001 EBITDA is ‪4.70 B‬ USD, and current EBITDA margin is 36.36%. See more stats in REGENERON PHARMACEUTICALS INC COM STK USD0.001 financial statements.